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In this study, the evolutionarily conserved intracellular adaptor protein, receptor of activated C
kinase 1 (RACK1) was identiﬁed as a novel interaction partner of protein inhibitor of activated STAT
2 (PIAS2) using a yeast two-hybrid screening system. The direct interaction and co-localization of
RACK1 with PIAS2 was conﬁrmed by immunoprecipitation and immunoﬂuorescence staining anal-
ysis, respectively. The 5th to 7th Trp-Asp 40 (5–7WD40) repeats of RACK1 were identiﬁed as the min-
imal domain required for interaction with PIAS2 by deletion analysis. Furthermore, multiple PIAS2-
domains, particularly the ‘PINIT’ and RLD domains, bind the RACK1 5–7 WD40 domain.
Structured summary of protein interactions:
PIAS2 physically interacts with RACK1 by two hybrid (View interaction)
RACK1 and PIAS2 colocalize by ﬂuorescence microscopy (View interaction)
PIAS2 physically interacts with RACK1 by two hybrid pooling approach (View interaction)
PIAS2 and RACK1 colocalize by ﬂuorescence microscopy (View interaction)
PIAS2 physically interacts with RACK1 by anti bait coimmunoprecipitation (View Interaction: 1, 2)
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The human and mouse family of PIAS (protein inhibitor of acti-
vated STAT [signal transducer and activator of transcription]) pro-
teins consists of PIAS1, PIASx (also called PIAS2), PIAS3, and PIASy
proteins [1–7]. The human PIAS2 gene encodes two splice variants,
PIASxa and PIASxb [2–4]. The mouse PIAS2 gene has at least ﬁve
isoforms (isoforms 1–5), which differ in the N- and C-terminii as
a result of alternative splicing. PIAS proteins are characterized by
an N-terminal SAP (scaffold attachment factor, acinus, and PIAS),
a ‘PINIT’ motif, a C-terminal RLD (RING ﬁnger-like zinc bindingchemical Societies. Published by E
ator of transcription; PIAS2,
r of activated protein kinase C
unit 2-like 1; WD40, WD40
f-A/B, acinus and Pias; SUMO,
eptor; X-a-Gal, 5-bromo-4-
ecco’s modiﬁcation of Eagle’s
synthetic complete medium
FP, green ﬂuorescent protein;
dino-2-phenylindole; TRITC,domain) and an acidic domain [8–11]. PIAS proteins have SUMO
E3-ligase activity and interaction of PIAS proteins with transcrip-
tion factors often results in sumoylation of that protein [12–15].
In addition to sumoylation, PIAS proteins regulate gene expression
by blocking the interaction of transcription factors with target
DNA, by recruiting co-repressors and co-activators of transcription
and by targeting proteins to nuclear bodies [16,17].
Although PIAS proteins were originally identiﬁed as proteins
that bind to and inhibit STATs, the functions of PIAS proteins are
clearly not limited to the regulation of STATs. PIAS proteins are
capable of interactingwith andmodulating (activating and repress-
ing) transcriptional activities of several transcription factors,
including the androgen receptor (AR) [18–20].
In this study, RACK1 (receptor of activated C kinase 1) was
identiﬁed as a PIAS2 partner through yeast two-hybrid screening
of cDNA libraries derived from mouse spermatogonial stem cells
and mouse stem cells using PIAS2 as bait. RACK1 is a homolog
of the b-subunit of heterotrimeric G proteins, involved in mem-
brane anchorage of multiple proteins including protein kinase C
[21]. The detection of the PIAS2/RACK1 interaction in mammalian
cells suggests that this interaction occurs in vivo. The minimal
interacting regions of RACK1 and PIAS2 were identiﬁed by deletion
analysis.lsevier B.V. All rights reserved.
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2.1. Yeast two-hybrid screening
The common cDNA fragment of the mouse PIAS2 gene (9–401aa
corresponding to nucleotides (nt) 213–1391 of NM_008602) was
cloned into the pGBKT7 vector containing the GAL4 DNA-binding
domain to generate the bait plasmid, pGBKT7–PIAS2. This con-
struct did not show toxic effects or autonomous transcriptional
activation following transformation into the yeast strain, Y187.
The mouse spermatogonial stem cell cDNA library and the mouse
stem cell cDNA library were constructed in a pGADT7-Rec vector
containing a GAL4 activation domain using Matchmaker Library
Construction and Screening Kits (Clontech, Santa Clara, USA) and
then transformed into the yeast AH109 strain. Yeast two-hybrid
screening was performed using the MATCHMAKER two-hybrid sys-
tem (Clontech). Positive clones were selected based on their ability
to grow on synthetic dropout (SD) medium/-LTHA/X-a-Gal and for
X-a-Gal activity.
2.2. Clone isolation and interaction analysis
Plasmid DNA of prey clones was isolated (Qiagen, Hilden,
Germany) and transformed into Escherichia coli DH5a. Prey clones
were recovered by ampicillin resistance and cDNA inserts were
identiﬁed by PCR ampliﬁcation, sequencing, and BLAST alignment.
Interaction between the bait and identiﬁed prey clones was veri-
ﬁed by co-transforming the puriﬁed prey plasmid with the bait
pGBKT7–PIAS2 construct into the yeast AH109 strain followed by
selection on SD/-LTHA medium. Co-transforming of pGBKT7-p53
with pGADT7-SV40 was used to be a positive control. Meanwhile,
a negative control was also included by co-transforming of
pGBKT7-p53 with pGADT7 vector into the same yeast cells.
2.3. Deletion mutant constructs of RACK1 and PIAS2 clones
Eight deletion mutant constructs of RACK1 163–326 in pGADT7
were constructed by sequential deletion of individual WD domains
from the C- or N-terminii of the fragment. Ampliﬁed inserts were
cloned into the pGEMT-Easy vector (Promega, Madison, USA) and
subcloned into the pGADT7 vector. Correct identity and cloning
orientation was conﬁrmed by restriction digestion analysis and
sequencing. Deletion mutant constructs were co-transformed with
pGBKT7–PIAS2 into yeast strain AH109 and the resulting transfor-
mants were cultured on SD medium/-LTHA/X-a-Gal.
A panel of PIAS2 9–401aa deletion mutants were generated by
PCR ampliﬁcation of various portions of PIAS2 that were cloned
into the pGBKT7 vector to create fusions with the C-terminal end
of the GAL4 DNA-binding domain. All PCR products and mutage-
nized constructs were veriﬁed by sequencing before use. Deletion
mutant constructs were co-transformed with pGADT7-RACK1
WD5–7 into yeast strain AH109 and the resulting transformants
were cultured on SD medium/-LTHA/X-a-Gal.
2.4. Expression constructs and antibody preparation
The common cDNA fragment of the mouse PIAS2 gene was
ampliﬁed by PCR and cloned into the pCMV-Myc and pDsRed
-Express-1 vector (Clontech) to generate pCMV-c-Myc-PIAS2 and
pDsRed-Express-1-PIAS2, respectively. Full-length RACK1 was
cloned into pEGFP-N1 (Clontech) to generate pEGFP-RACK1.
To prepare PIAS2 polyclonal antibody, the common cDNA frag-
ment of the PIAS2 gene was ampliﬁed and cloned into the pET28a
expression vector (Novagen, Madison, WI) and used to transform
Escherichia coli BL21 (DE3). The recombinant protein expressionwas induced with IPTG (isopropyl-1-thio-b-D-galactopyranoside)
and the protein was puriﬁed with the Ni-activated His-binding
resin (Yueda Company, Shanghai, China). The puriﬁed recombinant
protein was refolded by graded urea series. Production of puriﬁed
recombinant PIAS2 was used to immunize mice. The animals were
killed ten days after the last boost, and titers above 1:10000 were
observed in all animals by ELISA analysis. Then antibodies were
used for immunoprecipitation and Western Blot analysis.
The following commercially available antibodies were used for
immunoprecipitation and Western blot analysis: monoclonal anti-
c-Myc antibody (Millipore Biotechnology, Bedford, MA, USA) and
rabbit anti-RACK1 polyclonal antibody (Abcam, Cambridge, UK).2.5. Cell culture and transfection
HeLa cells (human epithelial carcinoma line) were cultured and
maintained in DMEM (Invitrogen) supplemented with 10% fetal
bovine serum at 37 C in a humidiﬁed atmosphere containing 5%
CO2. Transient transfection of HeLa cells (75–90% conﬂuence)
was performed using Lipofectamine 2000 (Invitrogen, Carlsbad,
USA) according to the instructions provided by the manufacturer.2.6. Co-immunoprecipitation and Western blot analysis
Since both PIAS2 and RACK1 were expressed in HeLa cells, the
whole cell lysates were used to test for an association between
endogenous PIAS2 and RACK1. In brief, the cells were washed with
ice-cold PBS and harvested in 500 ml lysis buffer (150 mM NaCl,
50 mM Tris pH 8, 1% Nonidet P-40, 0.5% deoxycholate, and a prote-
ase inhibitor mixture [Roche Applied Science, Mannheim,
Germany]). After incubation in lysis buffer for 60 min on ice, ly-
sates were clariﬁed by centrifugation for 20 min at 14000 rpm at
4 C. Speciﬁc antibodies (8 lg) or its control IgG were added to
the supernatant and incubated for 120 min at 4 C prior to addition
of 50 ll protein G-agarose followed by an overnight incubation at
4 C. Samples were then centrifuged for 1 min in a microcentrifuge
and washed with 1 ml lysis buffer, 1 ml washing buffer 2 (500 mM
NaCl, 50 mM Tris pH 7.5, 0.1% Nonidet P-40, 0.05% deoxycholate)
and 1 ml washing buffer (10 mM Tris pH 8, 0.1% Nonidet P-40,
0.05% deoxycholate). Initial lysates and immunoprecipitated pro-
teins were analyzed by SDS–PAGE and immunoblotting was car-
ried out using speciﬁc antibodies. Proteins were electrophor
etically transferred to nitrocellulose membranes (Amersham Bio-
sciences, Amersham, UK) and probed with the appropriate anti-
bodies. Bound antibodies were visualized with horseradish
peroxidase (HRP)-conjugated anti-rabbit or anti-mouse (Sigma)
IgG antibodies using the enhanced chemiluminescence system
(ECL, Thermo Scientiﬁc, MA, USA).2.7. Immunoﬂuorescence staining and imaging
To detect PIAS2 and RACK1, HeLa cells plated on round cover-
slips were transiently transfected with the pCMV-c-Myc-PIAS2
construct. After 24 h, cells were washed twice with PBS and ﬁxed
in 4% paraformaldehyde. Where indicated, cells were permeabili-
zed with 0.1% Triton X-100 and further incubated for 1 h at room
temperature with monoclonal mouse anti-c-Myc antibody and
rabbit anti-RACK1 polyclonal antibody. Proteins were detected by
incubation with TRITC-conjugated anti-mouse IgG and FITC-conju-
gated anti-rabbit IgG secondary antibodies for 90 min. Finally, cov-
erslips were washed and mounted with Vectashield DAPI
mounting medium (Vector Laboratories, Burlingame, CA, USA)
and visualized by ﬂuorescence microscopy.
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3.1. Identiﬁcation of RACK1 as a PIAS2-interacting protein using a
yeast two-hybrid screening system
To identify mouse proteins that interact with PIAS2, cDNA
libraries derived frommouse spermatogonial stem cells and mouse
stem cells were screened using a yeast two-hybrid system with the
bait plasmid pGBKT7–PIAS2. Growth of yeast strain Y187 co-trans-
formed with this construct and the empty prey plasmid pGADT7
was not supported on SD/-LTHA medium conﬁrming that the bait
was not auto-activated. A total of 5  106 primary transformants
were screened, yielding over 150 positive clones, 58 of which dem-
onstrated strong growth on SD/-LTHA medium. These clones were
isolated, sequenced and aligned using the NCBI BLAST alignment
search tool. Two independent clones encoded GNB2L1 (guanine
nucleotide-binding protein subunit 2-like 1), also known as RACK1,
spanning regions of 182 amino acids (RACK1 aa136–317) and 195
amino acids (RACK1 aa123–317), respectively, of the PIAS2 protein.
To conﬁrm these results, the PIAS2–RACK1 interaction was further
investigated using a direct yeast hybrid screening system. Strong
growth on SD/-LTHA medium was observed only in yeast cells
co-transformed with pGBKT7–PIAS2 and pGADT7–RACK1 (Fig. 1),
indicating interaction of RACK1 with PIAS2 in yeast.
3.2. RACK1 interacts with PIAS2 in vivo
RACK1 is an evolutionarily conserved protein belonging to the
family of proteins that contain WD40 repeats, a domain involved
in protein–protein interactions. Furthermore, RACK1 has been
shown to interact with a wide range of proteins leading to the
hypothesis that RACK1 acts as an adaptor protein [21–27]. The data
obtained from the yeast two-hybrid screen was conﬁrmed by evi-
dence of a direct interaction between PIAS2 and RACK1 in mamma-
lian cells. Co-immunoprecipitation andWestern blot analyses were
performed with proteins extracted from the human epithelial car-
cinoma HeLa cell line. RACK1 protein was immunoprecipitated
from HeLa cells using a mouse polyclonal PIAS2 antibody prior to
detection of RACK1 by Western blotting. And PIAS2 protein wasFig. 1. Yeast two-hybrid bait and prey constructs and direct yeast two-hybrid
analysis. (A) Bait construct. The common cDNA fragment of the mouse PIAS2 gene
(9–401aa corresponding to nucleotides (nt) 213–1391 of NM_008602) was cloned
into the pGBKT7 vector containing the GAL4 DNA-binding domain to generate the
bait plasmid, pGBKT7–PIAS2. Two independent prey clones of RACK1 protein were
identiﬁed. (B) Direct yeast two-hybrid analysis was used to conﬁrm the interaction
between RACK1 and PIAS2. Clone 1 is the positive control (pGBKT7-p53 and
pGADT7-SV40 antigen). Clones 2 and 3 are RACK1 clone 1 and clone 2 co-
transformed with the PIAS2 plasmid, respectively. Clone 4 is the negative control
(pGBKT7-p53 and pGADT7).also immunoprecipitated from HeLa cells using a rabbit RACK1
antibody prior to detection of PIAS2 by Western blotting. As shown
in Fig. 2, a 35kD band or a 63Kd band corresponding to RACK1 and
PIAS2 were observed in the co-immunoprecipitate and total lysate
(input). These results indicated that RACK1 can interact with PIAS2
in mammalian cells.
3.3. Co-localization of RACK1 with PIAS2 in HeLa cells
Further conﬁrmation of the interaction between RACK1 and
PIAS2 proteins was obtained by immunostaining of pCMV-c-Myc-
PIAS2 transfected HeLa cells. Two days after transfection, cells
were stained with monoclonal mouse anti-c-Myc and rabbit anti-
RACK1 polyclonal antibodies and protein expression was detected
using TRITC-conjugated anti-mouse IgG and FITC-conjugated anti-
rabbit IgG secondary antibodies, respectively. Cell nuclei were
identiﬁed by DAPI (4,6-diamidino-2-phenylindole) staining. Stain-
ing was visualized by confocal laser microscopy (Fig. 3A). Micros-
copy showed that RACK1 (Fig. 3A, green) and PIAS2 (Fig. 3A, red)
were co-localized in the whole cells (yellow) (Fig. 3A, MERGE).
The co-localiztion was also demonstrated by co-transfected
pDsRed-Express-1-PIAS2 and pEGFP-RACK1 into Hela cells. As
shown in Fig. 3B, GFP-RACK1 protein was uniformly distributed
in the cells (Fig. 3B, green). And PIAS2 protein was scattered
expressed in Hela cells (Fig. 3B, red). The merged image (Fig. 3B,
yellow) revealed that RACK1 and PIAS2 were partially co-localized
in Hela cells, indicating that RACK1 interacts with PIAS2 in Hela
cells.
3.4. RACK1 5–7 WD40 repeats domain is essential for binding to PIAS2
The presence of WD40 repeats, which have been implicated in
protein–protein interactions, within RACK1 suggested that one of
these motifs may be responsible for the interaction with PIAS2
[28,29]. The two independent clones isolated using the yeast two-
hybrid screening system, RACK1 123–317 aa and RACK1 136–317
aa, contained 3–7 and 4–7WD40 repeats, respectively. Theminimal
domain of RACK1 required to interact with PIAS2 was investigated
by deletion of residues from the N terminus of RACK1 123–317 aa
or the C terminus of RACK1 1–317 aa. The 50-truncated deletionmu-
tants of RACK1 encoded RACK1 3–7, 4–7, 5–7, 6–7 and 7 WD40 re-
peats. The 30-truncated deletion mutants of RACK1 encoded RACK1
1–4, 1–5 and 1–6 WD40 repeats. Deletion mutant constructs were
analyzed for their ability to interact with PIAS2 in yeast. Resultant
transformants were cultured on media lacking adenine, leucine,
histidine and tryptophan selecting for both plasmids and for an
interaction between the proteins encoded by these plasmids. Inter-
action between PIAS2 and RACK1 3–7, 4–7 and 5–7 deletion mu-
tants was observed. No interaction was observed between the
other RACK1 deletionmutants and PIAS2 (Fig. 4). These results indi-Fig. 2. PIAS2 co-immunoprecipitates with RACK1. HeLa cells were homogenized in
lysis buffer. Then the cell lysates were incubated with anti-RACK1 antibody, Rabbit
IgG (RIgG), anti-PIAS2 antibody and mouse IgG (MIgG) for immunoprecipitation
(IP), respectively. Co-immunoprecipitants (Co-IP) were analyzed by Western Blot
(WB) with anti-PIAS2 and anti-RACK1 antibodies, respectively. The total lysates
(Input) were also analyzed.
Fig. 3. Co-localization of RACK1 with PIAS2 in HeLa cells. (A) PIAS2 (red) and RACK1
(green) protein were visualized by immunostaining with monoclonal mouse anti-c-
Myc and rabbit anti-RACK1 polyclonal antibodies and protein expression was
detected using TRITC-conjugated anti-mouse IgG and FITC-conjugated anti-rabbit
IgG secondary antibodies, respectively. Cell nuclei were stained by DAPI (blue).
Staining was visualized by confocal laser microscopy. The merged image shows
regions of signal overlap (yellow). (B) Hela cells were transfected with expression
vectors for DsRed-PIAS2 and EGFP-RACK1 by Lipofectamine 2000. Two days after
transfection, the cells were detected by ﬂuorescence microscopy. The two ﬁgures
[PIAS2 (red) and RACK1 (green)] have been merged.
Fig. 4. WD40 repeats 5–7 of RACK1 are essential for binding to PIAS2. (A)
Constructs encoding various regions of RACK1 were cloned into pGADT7 and
analyzed for their ability to interact with PIAS2. The prey full length RACK1 protein
including seven WD40 repeats is represented at the top. Constructs 1–8 represent
truncated RACK1 deletion mutants. The interactions of truncated RACK1 deletion
mutants with PIAS2 is represented by  and +. (B) Interaction of truncated RACK1
deletion mutants (1–8, as shown in A) with PIAS2 in yeast strain AH109.
Fig. 5. Identiﬁcation of the PIAS2-domain required for interaction with RACK1 5–7
WD40 domain. (A) Deletion analysis of the PIAS2-domains required for RACK1. The
bait PIAS2 protein, including the location of known domains (1). PIAS2 amino acids
expressed by each cDNA clone in pGBKT7 (1–5). Approximate relative yeast two-
hybrid growth rates following co-transfection with the RACK1 5–7 WD40 prey
plasmid are represented by ++++, ++, and +. Results suggested that multiple
domains of the PIAS2 interacted with RACK1 5–7 WD40 domains, including the
‘PINIT’ and RLD domains. (B) Interaction of truncated PIAS2 clones with RACK1 5–7
WD40 domains in yeast strain AH109. Yeast containing the truncated bait PIAS2
(from 1–5, as indicated in A and B) and the prey RACK1 5–7WD40 domain plasmids
cultured on SD/-LTHA plates.
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3.5. Identiﬁcation of the PIAS2-domain required for interaction with
RACK1 5–7 WD40 repeats
In order to identify the PIAS2-domain required for interaction
with RACK1 5–7 WD40 repeats, a series of N- and C-terminal trun-
cated deletion mutants of PIAS2 9–401aa were generated and
introduced in the pGBKT7 vector. These truncated mutants and
pGADT7-RACK1 5–7WD40 repeats were co-transformed into yeastAH109 and the resulting transformants were cultured on selection
medium (Fig. 5). Similar interaction was observed between RACK1
5–7 WD40 repeats and PIAS2 9–345aa, PIAS2 346–401aa and
126 Y. Zheng et al. / FEBS Letters 586 (2012) 122–126PIAS2 9–401aa. PIAS2 9–242aa showed weak binding to RACK1
5–7 WD40 repeats and PIAS2 243–401aa binding was weaker still.
It has been reported that PIAS2 protein contains several character-
ized domains. The SAP domain of PIAS2 (PIAS2 9–242aa) can bind
to A/T-rich DNA and may involved in targeting PIAS proteins to
nuclear scaffold [30]. The ‘PINIT’ motif is essential for nuclear
retention of PIAS proteins [11]. So we supposed that the SAP do-
main may interact with RACK1 in nuclear of cells. When the ‘PINIT’
motif was disrupted from SAP domain, the protein may be ex-
ported from nuclear. And then the interaction will be inhibited.
In contrast, the RLD domain (PIAS2 346–401aa) mediates the
SUMO-E3-ligase activity of PIAS proteins and binds directly to
Ubc9, the SUMO E2 enzyme. Deletion of the PINIT motif from
RLD domain may facilitate this region releasing from nuclear and
then interact with RACK1 in the cytoplasm of the cells. All in all,
these results suggest that multiple PIAS2-domains, particularly
the ‘PINIT’ and RLD domains, are involved in binding of RACK1
5–7 WD40 repeats.
In conclusion, this study identiﬁed RACK1 as a binding partner
of PIAS2. Furthermore, WD40 repeats 5–7 of RACK1 were identiﬁed
as the minimal domain required for interaction with PIAS2, while
multiple domains of PIAS2, particularly the ‘PINIT’ and RLD do-
mains, bind to the RACK1 protein.
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